§ 1621q. Prevention, control, and elimination of communicable and infectious diseases
584 words·~3 min read·
/usc/title-25/section-1621qA research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Grants authorized The Secretary, acting through the Service, and after consultation with the Centers for Disease Control and Prevention, may make grants available to Indian tribes and tribal organizations for the following:
(1)Projects for the prevention, control, and elimination of communicable and infectious diseases, including tuberculosis, hepatitis, HIV, respiratory syncytial virus, hanta virus, sexually transmitted diseases, and H. pylori.
(2)Public information and education programs for the prevention, control, and elimination of communicable and infectious diseases.
(3)Education, training, and clinical skills improvement activities in the prevention, control, and elimination of communicable and infectious diseases for health professionals, including allied health professionals.
(4)Demonstration projects for the screening, treatment, and prevention of hepatitis C virus (HCV).
(b)Application required The Secretary may provide funding under subsection
(a)only if an application or proposal for funding is submitted to the Secretary.
(c)Coordination with health agencies Indian tribes and tribal organizations receiving funding under this section are encouraged to coordinate their activities with the Centers for Disease Control and Prevention and State and local health agencies.
(d)Technical assistance; report In carrying out this section, the Secretary—
(1)may, at the request of an Indian tribe or tribal organization, provide technical assistance; and
(2)shall prepare and submit a report to Congress biennially on the use of funds under this section and on the progress made toward the prevention, control, and elimination of communicable and infectious diseases among Indians and urban Indians.
(Pub. L. 94–437, title II, § 218, as added Pub. L. 102–573, title II, § 214, Oct. 29, 1992, 106 Stat. 4556; amended Pub. L. 103–437, § 10(e)(1), (2)(B), Nov. 2, 1994, 108 Stat. 4589; Pub. L. 111–148, title X, § 10221(a), Mar. 23, 2010, 124 Stat. 935.)
Connections9 cite this · traces to 3
Cited by 9 sections
public-private-law
register
statute-compilations
statutes-at-large
Traces to 3 documents
12 references not yet in our index
- Pub. L. 94–437, title II, § 218
- Pub. L. 102–573, title II, § 214
- 106 Stat. 4556
- Pub. L. 103–437, § 10(e)(1)
- 108 Stat. 4589
- Pub. L. 111–148, title X, § 10221(a)
- 124 Stat. 935
- Pub. L. 111–148
- section 10221(a) of Pub. L. 111–148
- Pub. L. 103–437
- 134 Stat. 208
- 42 U.S.C. 320b–5(g)
Citation graph
cites case law
§ 1621q
Prevention, control, and elimination of communicable and infectious diseases
Fed. Reg.×3
Stat. Comp.×2
Stat.×2
Bills×1
Pub. L.×1
Pub. L.Pub. L. 94–437, title II, § 218
Pub. L.Pub. L. 102–573, title II, § 214
Stat.106 Stat. 4556
Pub. L.Pub. L. 103–437, § 10(e)(1)
Stat.108 Stat. 4589
Cites 15 · showing 8Cited by 9 across 5 sources